Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ThermoGenesis CEO Steps Down As Firm Restructures

This article was originally published in The Gray Sheet

Executive Summary

With the resignation of ThermoGenesis CEO William Osgood, the stem cell technology maker will reorganize to focus on key products and generate near-term growth

You may also be interested in...



People In Brief

Childress back at HELP: Mark Childress rejoins the Senate Health, Education, Labor and Pensions Committee as senior adviser for national health reform. He briefly was chief of staff at the Department of Health and Human Services, one of the staff selections of former HHS Secretary-nominee Tom Daschle. But his departure was expected after Daschle withdrew his nomination. A member of the Obama transition team, Childress left a partnership at Foley Hoag to take the HHS appointment; he had been Daschle's chief counsel and policy director from 2000 to 2005. This will be Childress' second tour at the Senate panel, having worked there from 1989 to 1995 as chief counsel. At HHS, it appears that Laura Petrou, also a former Daschle aide, will step in as chief of staff, at least temporarily

Australia Looking Into In-Vitro Self-Test Deregulation

In-vitro self-tests for influenza and sexually transmitted diseases as well as direct-to-consumer genetic tests are on the agenda for deregulation in Australia. 
UsernamePublicRestriction

Register

MT026907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel